Latest filing published 12 Aug 2026 for Merck & Co., Inc., €622k.
Richard R. DeLuca has 47 filings, all at Merck & Co., Inc., with the listed title EVP&Pres, Merck Animal Heallth. The record is mostly about sales: 19, for EUR 64,907,750, with a median of EUR 2,317,795, and no purchase.
The three largest are dated October 28, 2022 (EUR 16,551,775), October 29, 2021 (EUR 10,147,603) and May 1, 2023 (EUR 7,979,439). Grants and option exercises account for 14 filings each.
The yearly calendar is marked by 2026: 12 filings already, ahead of 7 in 2019, 6 in 2021 and 2023, and just 1 in each of 2016, 2017, 2020 and 2025. Twelve filings fall in the last twelve months, 9 of them sales.
Jennifer Zachary has 12 trades within 30 days of trades by Richard R. DeLuca, David Michael Williams 11 and Chirfi Guindo 9, all in the same direction. Filings are published a median of 2 days after the trade.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 47 declarations